Estrogen prophylaxis. The U.S. Preventive Services Task Force.
Although routine postmenopausal estrogen replacement is not recommended, estrogen therapy should be considered for asymptomatic women who are at increased risk for osteoporosis, who lack known contraindications and who have received adequate counseling about potential benefits and risks.